Your provider can help determine whether its a good fit, especially if you have conditions like seizure disorders or eating disorders that may affect safety
Too little means overdosing
We pay special attention to any history of medical conditions, such as medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, to ensure patient safety
(And that was in just 30 weeks.) In trials of Wegovy (which has a higher dose of semaglutide than Ozempic), patients who took it for two years lost an average of 15.2 percent of their body weight, while over a third dropped at least 20 percent, nearly double that of any other weight-loss medication on the market
Among the most effective options available
If you notice symptoms getting worse or sticking around longer than usual, its a good time to talk with your healthcare provider